Novotech Acquires EastHORN Clinical Services
January 10, 2023
Novotech, the Asia-Pacific biotech specialist CRO, has acquired European contract research organization EastHORN Clinical Services to strengthen its global operations and European infrastructure. EastHORN — established in 2004 with more than 250 employees and operations across 30+ European countries — will retain its brand while being integrated into Novotech's systems to offer clients expanded in‑country expertise and access to Novotech's Asia‑Pacific and US capabilities.
- Buyers
- Novotech
- Targets
- EastHORN Clinical Services
- Industry
- Healthcare Services
- Location
- Scotland, United Kingdom
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Novotech Acquires US-based Regulatory Consulting Firm CBR International
January 9, 2023
Healthcare Services
Novotech, an Asia-Pacific–focused clinical research organization (CRO), has acquired US-based regulatory and drug development consultancy CBR International. The acquisition strengthens Novotech's US FDA regulatory, scientific and clinical development capabilities to better support biotech and pharma clients across the US, Europe and Asia-Pacific.
-
Everest Clinical Research Acquires Brightech International
December 2, 2022
Healthcare Services
Everest Clinical Research, a PE-backed full-service contract research organization, has acquired Brightech International, a specialist CRO focused on biostatistics, statistical programming, and clinical data management. The deal strengthens Everest's biometrics capabilities and global footprint, complementing its therapeutic strengths in Oncology, CNS, and Immunology.
-
Veranex Acquires HORUS Scientific
May 1, 2024
Healthcare Services
Veranex has acquired HORUS Scientific, a pathology and histology provider, to deepen its preclinical pathology and histology capabilities and expand its North American service footprint. The acquisition adds specialized GLP-capable histopathology services to Veranex’s integrated medtech service platform and complements its existing Paris pathology capabilities.
-
EVERSANA Acquires Cornerstone Research Group
October 30, 2019
Healthcare Services
EVERSANA has agreed to acquire Canada-based Cornerstone Research Group, a health economics and outcomes research (HEOR) firm headquartered in Burlington, Ontario. The acquisition adds HEOR, economic modeling, evidence synthesis and market access capabilities to EVERSANA’s integrated commercial services platform to better support pharmaceutical and medical device clients globally.
-
Veeda Clinical Research Acquires European CRO Heads
March 26, 2024
Healthcare Services
Veeda Clinical Research Limited has acquired Heads, a privately held European contract research organization (CRO) specializing in oncology clinical trials. The acquisition gives Veeda an expanded global footprint (Heads operates across ~25 locations) and integrated oncology clinical development capabilities, positioning Veeda as a full-service global CRO.
-
Everest Clinical Research (Arlington) Acquires August Research
November 7, 2023
Healthcare Services
Everest Clinical Research, a portfolio company of Arlington Capital Partners, has acquired European contract research organization August Research. The deal expands Everest's European footprint and clinical trial (CTS) and pharmacovigilance (PV) capabilities across 14 countries; August's founders will remain with the business. Financial terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.